Viewing Study NCT00330369


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2025-12-25 @ 8:25 PM
Study NCT ID: NCT00330369
Status: COMPLETED
Last Update Posted: 2014-03-18
First Post: 2006-05-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module